Xilio Therapeutics, Inc. (XLO)
NASDAQ · Healthcare
Xilio Therapeutics, Inc. Cash on Hand 2024–2025
Xilio Therapeutics, Inc. annual/quarterly cash on hand history from 2024 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Xilio Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 137.5M, a 148.74% increase year-over-year.
- Xilio Therapeutics, Inc. cash on hand for 2025 were 137.5M, a 148.74% increase from 2024.
- Xilio Therapeutics, Inc. cash on hand for 2024 were 55.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Xilio Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $138 |
| 2024 | $55 |
| Xilio Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $138 |
| 2024-12-31 | $55 |
Xilio Therapeutics, Inc. Cash on Hand — FAQ
Xilio Therapeutics, Inc. (XLO) cash on hand over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XLO's cash on hand history?
The chart and table above show Xilio Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.